ArticleOrphanet journal of rare diseases2021

Elosulfase alfa in the treatment of mucopolysaccharidosis type IVA: insights from the first managed access agreement.

Bob Stevens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.